Stanford University
Showing 151-200 of 357 Results
-
Feng Jiang
Postdoctoral Scholar, Genetics
BioI am a postdoctoral researcher working on RNA editing.
-
Peter William Earl Kane
Founder, Research to the People, Genetics
BioPeter runs Research to the People, a program for open patient-partnered research in oncology and rare disease.
-
Mark A. Kay, M.D., Ph.D.
Dennis Farrey Family Professor of Pediatrics, and Professor of Genetics
Current Research and Scholarly InterestsMark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.
-
Karla Kirkegaard
Violetta L. Horton Professor and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsThe biochemistry of RNA-dependent RNA polymerase function, the cell biology of the membrane rearrangements induced by positive-strand RNA virus infection of human cells, and the genetics of RNA viruses, which, with their high error rates, live at the brink of error catastrophe, are investigated in the Kirkegaard laboratory.
-
Teri Klein
Professor (Research) of Biomedical Data Science, of Medicine (BMIR) and, by courtesy, of Genetics
Current Research and Scholarly InterestsCo-founder, Pacific Symposium on Biocomputing
NIEHS, Site Visit Reviewer
NIH, Study Section Reviewer -
Gabriele Kockelkoren
Postdoctoral Scholar, Genetics
BioGabriele has a strong background in both physics and molecular biology and, accordingly, he strives in interdisciplinary environments. After completing a cum laude BSc. and MSc. in Nanobiology at the Technical University of Delft in The Netherlands, Gabriele pursued a PhD at the University of Copenhagen under the supervision of Prof. Dimitrios Stamou. In his PhD, Gabriele studied the nanoscale spatial organization of G protein-coupled receptors (GPCRs) at the plasma membrane of living cells. Importantly, his work reveals heterogeneous spatial patterns of receptor density and activation, that are modulated in a drug-dependent manner. These findings identify GPCR spatial organization as an integral element of their activity and signaling. Currently, Gabriele is a Postdoctoral Fellow in the lab of Prof. Alice Ting developing programmable receptors for molecular sensing and controlling cellular behaviour.
-
Anshul Kundaje
Associate Professor of Genetics and of Computer Science
Current Research and Scholarly InterestsWe develop statistical and machine learning frameworks to learn predictive, dynamic and causal models of gene regulation from heterogeneous functional genomics data.
-
Linda (Yu-Ling) Lan
Postdoctoral Scholar, Genetics
BioLinda Lan, DVM, PhD is a postdoctoral fellow in the Snyder Lab. Her research focuses on understanding long-term illness post-acute infections by using a combination of different types of data (multi-omics) and wearable technologies. Currently, Linda is working on three projects.
The first project involves studying the shared mechanisms of long COVID, ME/CFS, and PTLDS using smartwatches and micro-sampling. The second project involves examining the role of autoantibodies in long COVID patients and COVID vaccine side effects. The third project involves exploring the changes in the molecular and physiological responses of astronauts during short space flights using multi-omics and wearable devices.
Linda previously conducted her PhD research at the University of Chicago, where she studied memory B cell responses to a chimeric-based universal influenza virus vaccine candidate. In her leisure time, she enjoys running, hiking, and listening to audiobooks. -
Samuel Lancaster
Scientific Director of the Metabolic Health Center, Genetics
BioScientific Director, Metabolic Health Center, Stanford University School of Medicine
-
Shachar Lev Ari
Visiting Instructor/Lecturer, Genetics
BioI am a member and former Chair of the Department of Health Promotion, in the School of Public Health, in the Faculty of Medicine at Tel-Aviv University, former director, and founder of the Integrative Medicine Center & Research Laboratory at the Tel- Aviv Medical Center, and Head of the Health Promotion Unit in the Integrated Cancer Prevention Center. My training is in cellular biology, integrative medicine, intervention research, and health promotion science. I received the Outstanding Israeli Researcher for Complementary and Integrative Medicine award. The goal of my research is to unravel the biology, physiology, and psychology of health promotion approaches and translate findings into interventions that effectively target salutogenic mechanisms underpinning the biopsychology of well-being. I initiated the "lasting change" study and will co-lead this project in my current role as visiting scholar, at Prof. Michael Snyder's Lab, a global leader in precision health at Stanford University.
https://en.wikipedia.org/wiki/Shahar_Lev-Ari -
Jin Billy Li
Professor of Genetics
On Partial Leave from 07/16/2024 To 11/15/2024Current Research and Scholarly InterestsThe Li Lab is primarily interested in RNA editing mediated by ADAR enzymes. We co-discovered that the major function of RNA editing is to label endogenous dsRNAs as "self" to avoid being recognized as "non-self" by MDA5, a host innate immune dsRNA sensor, leading us to pursue therapeutic applications in cancer, autoimmune diseases, and viral infection. The other major direction of the lab is to develop technologies to harness endogenous ADAR enzymes for site-specific transcriptome engineering.
-
Wen-yang Lin
Postdoctoral Scholar, Genetics
Current Research and Scholarly InterestsThe broad goal of my research interest is to identify intrinsic and extrinsic mediators of tumor growth and plasticity. My past research experiences will synergize with the expertise of Dr. Monte Winslow’s laboratory to allow the discovery of novel mechanisms of cancer progression. The integration of our molecular measurements with multiple types of ‘omics’ data will ultimately improve the diagnostic precision medicine.
-
Xiangping Lin
Postdoctoral Scholar, Genetics
BioXiangping Lin, Ph.D., is a Postdoctoral Scholar at Stanford University. He received his Ph.D. in Chemistry from Sorbonne Paris North University, Paris. Dr. Lin’s research focuses on analytical chemistry, especially mass spectrometry (Orbitrap, Q-TOF, QqQ) and NMR-based omics studies. These include, but are not limited to, metabolomics, exposomics, lipidomics, and the application in biomedical and environmental research, such as metabolism, liver disease, cancer, environmental chemicals exposure biomarkers. In addition, he has extensive experience in multivariate statistics (PCA, PLS-DA, et cetera.), variable selection (logistic regression, LASSO regression, et cetera.), and R programming. In his free time, he enjoys going to the gym, playing badminton (he organizes the Stanford postdoc badminton club), swimming, fitness, cuisine, traveling, and spending time with family and friends.
